{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:48:18Z","timestamp":1782895698176,"version":"3.54.5"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Southern and Central Africa International Center of Excellence for Malaria Research was supported by funding from the National Institute of Allergy and Infectious Diseases","award":["U19AI089680"],"award-info":[{"award-number":["U19AI089680"]}]},{"name":"Partial funding was provided by the Bill & Melinda Gates Foundation through a grant to PATH","award":["OPP1134518 \/ INV-009984 to D.J.B"],"award-info":[{"award-number":["OPP1134518 \/ INV-009984 to D.J.B"]}]},{"name":"Purdue Department of Biological Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45996-y","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:16:45Z","timestamp":1777551405000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["National genomic profiling of Plasmodium falciparum antimalarial resistance in Zambian children participating in the 2018 malaria indicator survey"],"prefix":"10.1038","volume":"16","author":[{"given":"Abebe A.","family":"Fola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilinca I.","family":"Ciubotariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Dorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulenga C.","family":"Mwenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Mambwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conceptor","family":"Mulube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Kasaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moonga B.","family":"Hawela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busiku","family":"Hamainza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Carpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"45996_CR1","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nm.4381","volume":"23","author":"B Blasco","year":"2017","unstructured":"Blasco, B., Leroy, D. & Fidock, D. A. Antimalarial drug resistance: Linking Plasmodium falciparum parasite biology to the clinic. Nat. Med. 23, 917\u2013928 (2017).","journal-title":"Nat. Med."},{"key":"45996_CR2","doi-asserted-by":"publisher","unstructured":"Menard, D., Dondorp, A. & Antimalarial Drug Resistance A Threat to Malaria Elimination. Cold Spring Harbor Perspectives in Medicine vol. 7 a025619 Preprint at (2017). https:\/\/doi.org\/10.1101\/cshperspect.a025619","DOI":"10.1101\/cshperspect.a025619"},{"key":"45996_CR3","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","volume":"19","author":"MD Conrad","year":"2019","unstructured":"Conrad, M. D. & Rosenthal, P. J. Antimalarial drug resistance in Africa: The calm before the storm?. Lancet Infect. Dis. 19, e338\u2013e351 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"45996_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003217","volume":"5","author":"F Amimo","year":"2020","unstructured":"Amimo, F. et al.\u00a0Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in Africa: a systematic analysis of national trends. BMJ Glob. Health. 5, e003217. https:\/\/doi.org\/10.1136\/bmjgh-2020-003217 (2020).","journal-title":"BMJ Glob. Health"},{"key":"45996_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-019-0527-7","volume":"8","author":"S Dhiman","year":"2019","unstructured":"Dhiman, S. Correction to: Are malaria elimination efforts on right track? An analysis of gains achieved and challenges ahead. Infect. Dis. Poverty 8, 19 (2019).","journal-title":"Infect. Dis. Poverty"},{"key":"45996_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.parepi.2020.e00188","volume":"11","author":"G Makenga","year":"2020","unstructured":"Makenga, G. et al. Prevalence of malaria parasitaemia in school-aged children and pregnant women in endemic settings of sub-Saharan Africa: A systematic review and meta-analysis. Parasite Epidemiol. Control 11, e00188 (2020).","journal-title":"Parasite Epidemiol. Control"},{"key":"45996_CR7","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1111\/febs.14127","volume":"284","author":"AM Thu","year":"2017","unstructured":"Thu, A. M., Phyo, A. P., Landier, J., Parker, D. M. & Nosten, F. H. Combating multidrug-resistant Plasmodium falciparum malaria. FEBS J. 284, 2569\u20132578 (2017).","journal-title":"FEBS J."},{"key":"45996_CR8","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1086\/322858","volume":"184","author":"TE Wellems","year":"2001","unstructured":"Wellems, T. E. & Plowe, C. V. Chloroquine-resistant malaria. J. Infect. Dis. 184, 770\u2013776 (2001).","journal-title":"J. Infect. Dis."},{"key":"45996_CR9","doi-asserted-by":"publisher","unstructured":"Djimd\u00e9, A. et al. A Molecular Marker for Chloroquine-Resistant Falciparum Malaria. New England Journal of Medicine vol. 344 257\u2013263 Preprint at (2001). https:\/\/doi.org\/10.1056\/nejm200101253440403","DOI":"10.1056\/nejm200101253440403"},{"key":"45996_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1086\/338566","volume":"185","author":"JG Kublin","year":"2002","unstructured":"Kublin, J. G. et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 185, 380\u2013388 (2002).","journal-title":"J. Infect. Dis."},{"key":"45996_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06708-9","volume":"7","author":"LC Okell","year":"2017","unstructured":"Okell, L. C., Griffin, J. T. & Roper, C. Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa. Sci. Rep. 7, 7389 (2017).","journal-title":"Sci. Rep."},{"key":"45996_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.actatropica.2012.10.013","volume":"125","author":"R Abdul-Ghani","year":"2013","unstructured":"Abdul-Ghani, R., Farag, H. F. & Allam, A. F. Sulfadoxine-pyrimethamine resistance in Plasmodium falciparum: A zoomed image at the molecular level within a geographic context. Acta Trop. 125, 163\u2013190 (2013).","journal-title":"Acta Trop."},{"key":"45996_CR13","doi-asserted-by":"publisher","unstructured":"Desai, M. et al. Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight. Clinical Infectious Diseases vol. 62 323\u2013333 Preprint at (2016). https:\/\/doi.org\/10.1093\/cid\/civ881","DOI":"10.1093\/cid\/civ881"},{"key":"45996_CR14","doi-asserted-by":"publisher","unstructured":"van Eijk, A. M. et al. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. The Lancet Infectious Diseases vol. 19 546\u2013556 Preprint at (2019). https:\/\/doi.org\/10.1016\/s1473-3099(18)30732-1","DOI":"10.1016\/s1473-3099(18)30732-1"},{"key":"45996_CR15","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1093\/infdis\/jiu836","volume":"211","author":"J Gutman","year":"2015","unstructured":"Gutman, J. et al. The A581G mutation in the gene encoding Plasmodium falciparum dihydropteroate synthetase reduces the effectiveness of sulfadoxine-pyrimethamine preventive therapy in Malawian pregnant women. J. Infect. Dis. 211, 1997\u20132005 (2015).","journal-title":"J. Infect. Dis."},{"key":"45996_CR16","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","volume":"379","author":"AP Phyo","year":"2012","unstructured":"Phyo, A. P. et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: A longitudinal study. Lancet 379, 1960\u20131966 (2012).","journal-title":"Lancet"},{"key":"45996_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","volume":"17","author":"M Imwong","year":"2017","unstructured":"Imwong, M. et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect. Dis. 17, 491\u2013497 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"45996_CR18","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1126\/science.352.6284.398","volume":"352","author":"L Roberts","year":"2016","unstructured":"Roberts, L. Malaria wars. Science 352, 398\u2013402, 404\u20135 (2016).","journal-title":"Science"},{"key":"45996_CR19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ng.2624","volume":"45","author":"O Miotto","year":"2013","unstructured":"Miotto, O. et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat. Genet. 45, 648\u2013655 (2013).","journal-title":"Nat. Genet."},{"key":"45996_CR20","unstructured":"World Health Organization. Report on Antimalarial Drug Efficacy, Resistance and Response: 10 Years of Surveillance (2010\u20132019) (World Health Organization, 2020)."},{"key":"45996_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-018-2242-4","volume":"17","author":"RF Grais","year":"2018","unstructured":"Grais, R. F. et al. Molecular markers of resistance to amodiaquine plus sulfadoxine\u2013pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger. Malar. J. 17, 1\u20139 (2018).","journal-title":"Malar. J."},{"key":"45996_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.mib.2007.07.007","volume":"10","author":"EH Ekland","year":"2007","unstructured":"Ekland, E. H. & Fidock, D. A. Advances in understanding the genetic basis of antimalarial drug resistance. Curr. Opin. Microbiol. 10, 363\u2013370 (2007).","journal-title":"Curr. Opin. Microbiol."},{"key":"45996_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0802-4","volume":"14","author":"P Guyant","year":"2015","unstructured":"Guyant, P. et al. Past and new challenges for malaria control and elimination: The role of operational research for innovation in designing interventions. Malar. J. 14, 279 (2015).","journal-title":"Malar. J."},{"key":"45996_CR24","doi-asserted-by":"publisher","unstructured":"Arya, A., Foko, K., Chaudhry, L. P., Sharma, S. & Singh, V. A. Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions \u2013 India and sub-Saharan Africa. International Journal for Parasitology: Drugs and Drug Resistance vol. 15 43\u201356 Preprint at (2021). https:\/\/doi.org\/10.1016\/j.ijpddr.2020.11.006","DOI":"10.1016\/j.ijpddr.2020.11.006"},{"key":"45996_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpddr.2021.06.001","volume":"16","author":"L Ndwiga","year":"2021","unstructured":"Ndwiga, L. et al. A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa. Int. J. Parasitol. Drugs Drug Resist. 16, 155\u2013161 (2021).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"45996_CR26","doi-asserted-by":"publisher","first-page":"e591","DOI":"10.1016\/S1473-3099(24)00141-5","volume":"24","author":"PJ Rosenthal","year":"2024","unstructured":"Rosenthal, P. J. et al. The emergence of artemisinin partial resistance in Africa: how do we respond? Lancet Infect. Dis. 24, e591\u2013e600 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"45996_CR27","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala, B. et al. Evidence of artemisinin-resistant malaria in Africa. N. Engl. J. Med. 385, 1163\u20131171 (2021).","journal-title":"N. Engl. J. Med."},{"key":"45996_CR28","doi-asserted-by":"crossref","unstructured":"Zeleke, A. J. et al. Artemisinin resistant kelch13 R622I and RDT negativity approaching predominance in northern Ethiopia and emerging C580Y of African origin threaten falciparum malaria control. Infectious Diseases (except HIV\/AIDS) (2025).","DOI":"10.1101\/2025.06.23.25330019"},{"key":"45996_CR29","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa2211803","volume":"389","author":"D Conrad Melissa","year":"2023","unstructured":"Conrad Melissa, D. et al. Evolution of partial resistance to artemisinins in malaria parasites in Uganda. N. Engl. J. Med. 389, 722\u2013732 (2023).","journal-title":"N. Engl. J. Med."},{"key":"45996_CR30","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana, A. et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat. Med. 26, 1602\u20131608 (2020).","journal-title":"Nat. Med."},{"key":"45996_CR31","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41591-021-01365-y","volume":"27","author":"A Uwimana","year":"2021","unstructured":"Uwimana, A. et al. Author correction: Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat. Med. 27, 1113\u20131115 (2021).","journal-title":"Nat. Med."},{"key":"45996_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/nyas.12766","volume":"1342","author":"S Takala-Harrison","year":"2015","unstructured":"Takala-Harrison, S. & Laufer, M. K. Antimalarial drug resistance in Africa: Key lessons for the future. Ann. N. Y. Acad. Sci. 1342, 62\u201367 (2015).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"45996_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijpddr.2021.07.004","volume":"17","author":"YD Ndiaye","year":"2021","unstructured":"Ndiaye, Y. D. et al. Genetic surveillance for monitoring the impact of drug use on Plasmodium falciparum populations. Int. J. Parasitol. Drugs Drug Resist. 17, 12\u201322 (2021).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"45996_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2020.105704","volume":"212","author":"L Sitali","year":"2020","unstructured":"Sitali, L. et al. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr\/Pfdhps genes. Acta Trop. 212, 105704 (2020).","journal-title":"Acta Trop."},{"key":"45996_CR35","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.4269\/ajtmh.20-0852","volume":"103","author":"MM Ippolito","year":"2020","unstructured":"Ippolito, M. M. et al. Therapeutic Efficacy of Artemether-Lumefantrine for Uncomplicated Falciparum Malaria in Northern Zambia. Am. J. Trop. Med. Hyg. 103, 2224\u20132232 (2020).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"45996_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaf188","author":"AC Martin","year":"2025","unstructured":"Martin, A. C. et al. Emergence and rising prevalence of artemisinin partial resistance marker Kelch13 P441L in a low malaria transmission setting in southern Zambia. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiaf188 (2025).","journal-title":"J. Infect. Dis."},{"key":"45996_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-024-00498-8","volume":"4","author":"AA Fola","year":"2024","unstructured":"Fola, A. A. et al. Genomics reveals heterogeneous Plasmodium falciparum transmission and selection signals in Zambia. Commun. Med. 4, 67 (2024).","journal-title":"Commun. Med."},{"key":"45996_CR38","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/infdis\/jiu358","volume":"210","author":"G Henriques","year":"2014","unstructured":"Henriques, G. et al. Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT. J. Infect. Dis. 210, 2001\u20132008 (2014).","journal-title":"J. Infect. Dis."},{"key":"45996_CR39","doi-asserted-by":"publisher","unstructured":"Adams, T. et al. Prevalence of Plasmodium falciparum delayed clearance associated polymorphisms in adaptor protein complex 2 mu subunit (pfap2mu) and ubiquitin specific protease 1 (pfubp1) genes in Ghanaian isolates. Parasites & Vectors vol. 11 Preprint at (2018). https:\/\/doi.org\/10.1186\/s13071-018-2762-3","DOI":"10.1186\/s13071-018-2762-3"},{"key":"45996_CR40","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1128\/AAC.50.2.480-489.2006","volume":"50","author":"A Afonso","year":"2006","unstructured":"Afonso, A. et al. Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2\u2009+\u2009ATPase), tctp, mdr1, and cg10. Antimicrob. Agents Chemother. 50, 480\u2013489 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"45996_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1637-3","volume":"15","author":"S Mwanza","year":"2016","unstructured":"Mwanza, S. et al. The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia. Malaria Journal 15, 584 (2016).","journal-title":"Malaria Journal"},{"key":"45996_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001616","volume":"20","author":"SH Shafik","year":"2022","unstructured":"Shafik, S. H., Richards, S. N., Corry, B. & Martin, R. E. Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT. PLoS Biol. 20, e3001616 (2022).","journal-title":"PLoS Biol."},{"key":"45996_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11553","volume":"7","author":"MI Veiga","year":"2016","unstructured":"Veiga, M. I. et al. Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat. Commun. 7, 11553 (2016).","journal-title":"Nat. Commun."},{"key":"45996_CR44","unstructured":"Wirth, D. F. & Alonso, P. L. Malaria: Biology in the Era of Eradication (Cold Spring Harbor Laboratory Press, 2017)."},{"key":"45996_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010993","volume":"18","author":"M Carrasquilla","year":"2022","unstructured":"Carrasquilla, M. et al. Resolving drug selection and migration in an inbred South American Plasmodium falciparum population with identity-by-descent analysis. PLoS Pathog. 18, e1010993 (2022).","journal-title":"PLoS Pathog."},{"key":"45996_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijpara.2016.08.006","volume":"47","author":"S Auburn","year":"2017","unstructured":"Auburn, S. & Barry, A. E. Dissecting malaria biology and epidemiology using population genetics and genomics. Int. J. Parasitol. 47, 77\u201385 (2017).","journal-title":"Int. J. Parasitol."},{"key":"45996_CR47","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1023\/A:1010077105257","volume":"1","author":"R B\u00f8dker","year":"2000","unstructured":"B\u00f8dker, R., Kisinza, W., Malima, R., Msangeni, H. & Lindsay, S. Resurgence of malaria in the Usambara Mountains, Tanzania, an epidemic of drug-resistant parasites. Global Change Hum. Health 1, 134\u2013153 (2000).","journal-title":"Global Change Hum. Health"},{"key":"45996_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15779-8","volume":"11","author":"R Verity","year":"2020","unstructured":"Verity, R. et al. The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC. Nat. Commun. 11, 2107 (2020).","journal-title":"Nat. Commun."},{"key":"45996_CR49","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/s41564-023-01377-z","volume":"8","author":"A Amambua-Ngwa","year":"2023","unstructured":"Amambua-Ngwa, A. et al. Chloroquine resistance evolution in Plasmodium falciparum is mediated by the putative amino acid transporter AAT1. Nat. Microbiol. 8, 1213\u20131226 (2023).","journal-title":"Nat. Microbiol."},{"key":"45996_CR50","doi-asserted-by":"crossref","unstructured":"Wamae, K. et al. No evidence of Plasmodium falciparum K13 artemisinin conferring mutations over a 24-year analysis in Coastal Kenya, but a near complete reversion to chloroquine wild type parasites. Antimicrob. Agents Chemother. 63, e01067-19 (2019).","DOI":"10.1128\/AAC.01067-19"},{"key":"45996_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-017-2298-y","volume":"10","author":"F Lu","year":"2017","unstructured":"Lu, F. et al. Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China. Parasit. Vectors 10, 355 (2017).","journal-title":"Parasit. Vectors"},{"key":"45996_CR52","doi-asserted-by":"publisher","unstructured":"Alifrangis, M. et al. Independent Origin ofPlasmodium falciparumAntifolate Super-Resistance, Uganda, Tanzania, and Ethiopia. Emerging Infectious Diseases vol. 20 1280\u20131286 Preprint at (2014). https:\/\/doi.org\/10.3201\/eid2008.131897","DOI":"10.3201\/eid2008.131897"},{"key":"45996_CR53","doi-asserted-by":"crossref","unstructured":"Siame, M. N. P., Mharakurwa, S., Chipeta, J., Thuma, P. & Michelo, C. High prevalence of dhfr and dhps molecular markers in Plasmodium falciparum in pregnant women of Nchelenge district, Northern Zambia. Malar. J. 14, 190 (2015).","DOI":"10.1186\/s12936-015-0676-5"},{"key":"45996_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-7-25","volume":"7","author":"N Sipilanyambe","year":"2008","unstructured":"Sipilanyambe, N. et al. From chloroquine to artemether-lumefantrine: The process of drug policy change in Zambia. Malar. J. 7, 25 (2008).","journal-title":"Malar. J."},{"key":"45996_CR55","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","volume":"21","author":"A Uwimana","year":"2021","unstructured":"Uwimana, A. et al. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect. Dis. 21, 1120\u20131128 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"45996_CR56","doi-asserted-by":"publisher","DOI":"10.1101\/2023.11.07.23298207","author":"JJ Juliano","year":"2023","unstructured":"Juliano, J. J. et al. Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania. medRxiv https:\/\/doi.org\/10.1101\/2023.11.07.23298207 (2023).","journal-title":"medRxiv"},{"key":"45996_CR57","doi-asserted-by":"publisher","unstructured":"Young, N. W. et al. High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing. medRxiv (2024). https:\/\/doi.org\/10.1101\/2024.04.29.24306442","DOI":"10.1101\/2024.04.29.24306442"},{"key":"45996_CR58","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ng.3189","volume":"47","author":"O Miotto","year":"2015","unstructured":"Miotto, O. et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat. Genet. 47, 226\u2013234 (2015).","journal-title":"Nat. Genet."},{"key":"45996_CR59","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1126\/science.aav5427","volume":"365","author":"A Amambua-Ngwa","year":"2019","unstructured":"Amambua-Ngwa, A. et al. Major subpopulations of Plasmodium falciparum in sub-Saharan Africa. Science 365, 813\u2013816 (2019).","journal-title":"Science"},{"key":"45996_CR60","doi-asserted-by":"publisher","DOI":"10.1101\/2024.06.05.24308497","author":"AA Fola","year":"2024","unstructured":"Fola, A. A. et al. Temporal genomic analysis of Plasmodium falciparum reveals increased prevalence of mutations associated with delayed clearance following treatment with artemisinin-lumefantrine in Choma District, Southern Province, Zambia. medRxiv https:\/\/doi.org\/10.1101\/2024.06.05.24308497 (2024).","journal-title":"medRxiv"},{"key":"45996_CR61","unstructured":"Zambia National Malaria Indicator Survey (MIS). (2018). https:\/\/www.path.org\/resources\/zambia-natl-malaria-indicator-survey-mis-2018\/"},{"key":"45996_CR62","doi-asserted-by":"publisher","unstructured":"Fola, A., Dorman, A., Levy, J., Ciubotariu, M. & Carpi, G. I. Optimized HT gDNA extraction from dried blood spot using QIAcube HT for malaria genomic epidemiology studies v1. (2020). https:\/\/doi.org\/10.17504\/protocols.io.bh69j9h6","DOI":"10.17504\/protocols.io.bh69j9h6"},{"key":"45996_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-1634-x","volume":"16","author":"G Carpi","year":"2015","unstructured":"Carpi, G. et al. Whole genome capture of vector-borne pathogens from mixed DNA samples: A case study of Borrelia burgdorferi. BMC Genomics 16, 434 (2015).","journal-title":"BMC Genomics"},{"key":"45996_CR64","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac314","volume":"23","author":"G Carpi","year":"2022","unstructured":"Carpi, G., Gorenstein, L., Harkins, T. T., Samadi, M. & Vats, P.\u00a0A GPU-accelerated compute framework for pathogen genomic variant identification to aid genomic epidemiology of infectious disease: A malaria case study. Brief. Bioinform. 23, bbac314 (2022).","journal-title":"Brief. Bioinform."},{"key":"45996_CR65","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv [q-bio.GN] (2013)."},{"key":"45996_CR66","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","volume":"33","author":"JR Conway","year":"2017","unstructured":"Conway, J. R., Lex, A. & Gehlenborg, N. UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics 33, 2938\u20132940 (2017).","journal-title":"Bioinformatics"},{"key":"45996_CR67","doi-asserted-by":"publisher","first-page":"439","DOI":"10.32614\/RJ-2018-009","volume":"10","author":"E Pebesma","year":"2018","unstructured":"Pebesma, E. Simple features for R: Standardized support for spatial vector data. R. J. 10, 439 (2018).","journal-title":"R. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45996-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45996-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45996-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:22:26Z","timestamp":1782894146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45996-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45996"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45996-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4888948\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All study participants, and\/or their parents or legal guardians, provided written informed consent. This study was approved by the Biomedical Research Ethics Committee of the University of Zambia (Ref 011-02-18) and the Zambian National Health Research Authority. All research procedures were conducted in accordance with the Declaration of Helsinki and relevant institutional and national guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}],"article-number":"20113"}}